Advanced Proteome Therapeutics Corporation
Advanced Proteome Therapeutics Corporation, through its subsidiary, Advanced Proteome Therapeutics Inc., operates as a biotechnology company in the United States. The company develops and commercializes a platform for the chemical modification of protein therapeutics. Its platform is dedicated to applications in the field of antibody drug conjugates, as well as focused on protein conjugates and i… Read more
Market Cap & Net Worth: Advanced Proteome Therapeutics Corporation (APTCF)
Advanced Proteome Therapeutics Corporation (PINK:APTCF) has a market capitalization of $8.23K ($8.23K) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #45426 globally and #14287 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Advanced Proteome Therapeutics Corporation's stock price $0.00 by its total outstanding shares 41127100 (41.13 Million).
Advanced Proteome Therapeutics Corporation Market Cap History: 2015 to 2025
Advanced Proteome Therapeutics Corporation's market capitalization history from 2015 to 2025. Data shows change from $24.64 Million to $8.23K (-58.03% CAGR).
Advanced Proteome Therapeutics Corporation Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Advanced Proteome Therapeutics Corporation's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of APTCF by Market Capitalization
Companies near Advanced Proteome Therapeutics Corporation in the global market cap rankings as of March 18, 2026.
Key companies related to Advanced Proteome Therapeutics Corporation by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Advanced Proteome Therapeutics Corporation Historical Marketcap From 2015 to 2025
Between 2015 and today, Advanced Proteome Therapeutics Corporation's market cap moved from $24.64 Million to $ 8.23K, with a yearly change of -58.03%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $8.23K | 0.00% |
| 2024 | $8.23K | 0.00% |
| 2023 | $8.23K | -99.78% |
| 2022 | $3.70 Million | -35.71% |
| 2021 | $5.76 Million | +16.67% |
| 2020 | $4.94 Million | +238.03% |
| 2019 | $1.46 Million | -84.96% |
| 2018 | $9.71 Million | -40.70% |
| 2017 | $16.37 Million | +42.14% |
| 2016 | $11.52 Million | -53.26% |
| 2015 | $24.64 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Advanced Proteome Therapeutics Corporation was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $8.23K USD |
| MoneyControl | $8.23K USD |
| MarketWatch | $8.23K USD |
| marketcap.company | $8.23K USD |
| Reuters | $8.23K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.